Company Details
sun-pharma
43,552
2,074,346
3254
sunpharma.com
0
SUN_5257905
In-progress

SUN PHARMA Company CyberSecurity Posture
sunpharma.comSun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe, and a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 3,000 scientists and R&D investments of over 6-8% of annual revenues. At Sun, our people are our greatest asset. Ours has never been a story of individual brilliance but of cultivating a culture of realising collective potential. In our journey, everyone is enabled to take charge in an environment that offers limitless growth opportunities. We are with you every step of the way, so you can shine for years to come. With the launch of our Employee Value Proposition (EVP), we define our promise to ‘Create Your Own Sunshine'—driven by the three pillars of Better Every Day, Take Charge, and Thrive Together. These pillars drive progress at Sun so that people can achieve what they would have thought impossible. Learn more about our EVP here: https://sunpharma.com/careers/
Company Details
sun-pharma
43,552
2,074,346
3254
sunpharma.com
0
SUN_5257905
In-progress
Between 800 and 849

SUN PHARMA Global Score (TPRM)XXXX



No incidents recorded for SUN PHARMA in 2025.
No incidents recorded for SUN PHARMA in 2025.
No incidents recorded for SUN PHARMA in 2025.
SUN PHARMA cyber incidents detection timeline including parent company and subsidiaries

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe, and a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 3,000 scientists and R&D investments of over 6-8% of annual revenues. At Sun, our people are our greatest asset. Ours has never been a story of individual brilliance but of cultivating a culture of realising collective potential. In our journey, everyone is enabled to take charge in an environment that offers limitless growth opportunities. We are with you every step of the way, so you can shine for years to come. With the launch of our Employee Value Proposition (EVP), we define our promise to ‘Create Your Own Sunshine'—driven by the three pillars of Better Every Day, Take Charge, and Thrive Together. These pillars drive progress at Sun so that people can achieve what they would have thought impossible. Learn more about our EVP here: https://sunpharma.com/careers/


At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine

Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages. Ever since its establishment in 1993, Hetero showed a tradition of excellence and deep sense of commitm
For almost 50 years, we’ve been creating high-quality medicines and making them accessible to the people who need them. We are a trusted, reliable partner and dependable source of over 800* high-quality generic, specialty and branded pharmaceutical products that hospitals, physicians and pharmacists

HPCC- Hyderabad pharmaceutical congress committee is an apex body representing Indian pharmacists working in various capacities, viz,pharmaceutical industry,research and development,quality control,quality assurance,academics,drug control departments,hospitals,community and clinical pharmacy,marketi

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and

Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneer
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out mor

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently addre
.png)
Tech News News: The FCC has reportedly voted to eliminate rules requiring minimum cybersecurity standards for US phone and internet...
HYDERABAD: City-based infrastructure giant has become the victim of an elaborate phishing scam, losing approximately Rs 5.5 crore.
International Business News: The Hague (Netherlands): The industrial automation sector is entering a new age where artificial intelligence...
Cybersecurity News: Dr Reddy's Laboratories lost Rs 2.16 crore to fraudsters who infiltrated an email thread and rerouted a payment to a...
Europe News: A recent security audit of the Louvre has exposed alarming cybersecurity lapses, including a video surveillance system password...
Pune: Cybersecurity experts on Wednesday cautioned people against sharing personal information on artificial intelligence (AI) platforms,...
Dilip Shanghvi, founder of Sun Pharma, has transformed a ₹10,000 startup into India"s largest pharmaceutical company with a turnover of...
Cybersecurity on Sale? Big Firms Hacked as Consulting Firms Cashed In — See Full List Inside! Major Companies in India Hacked or Victims of...
India Business News: Indian pharmaceutical stocks experienced a downturn following Donald Trump's renewed threat to impose tariffs on...

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
The official website of SUN PHARMA is http://www.sunpharma.com.
According to Rankiteo, SUN PHARMA’s AI-generated cybersecurity score is 811, reflecting their Good security posture.
According to Rankiteo, SUN PHARMA currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
According to Rankiteo, SUN PHARMA is not certified under SOC 2 Type 1.
According to Rankiteo, SUN PHARMA does not hold a SOC 2 Type 2 certification.
According to Rankiteo, SUN PHARMA is not listed as GDPR compliant.
According to Rankiteo, SUN PHARMA does not currently maintain PCI DSS compliance.
According to Rankiteo, SUN PHARMA is not compliant with HIPAA regulations.
According to Rankiteo,SUN PHARMA is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
SUN PHARMA operates primarily in the Pharmaceutical Manufacturing industry.
SUN PHARMA employs approximately 43,552 people worldwide.
SUN PHARMA presently has no subsidiaries across any sectors.
SUN PHARMA’s official LinkedIn profile has approximately 2,074,346 followers.
SUN PHARMA is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.
No, SUN PHARMA does not have a profile on Crunchbase.
Yes, SUN PHARMA maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/sun-pharma.
As of December 11, 2025, Rankiteo reports that SUN PHARMA has not experienced any cybersecurity incidents.
SUN PHARMA has an estimated 5,412 peer or competitor companies worldwide.
Total Incidents: According to Rankiteo, SUN PHARMA has faced 0 incidents in the past.
Incident Types: The types of cybersecurity incidents that have occurred include .
.png)
FreePBX Endpoint Manager is a module for managing telephony endpoints in FreePBX systems. Versions prior to 16.0.96 and 17.0.1 through 17.0.9 have a weak default password. By default, this is a 6 digit numeric value which can be brute forced. (This is the app_password parameter). Depending on local configuration, this password could be the extension, voicemail, user manager, DPMA or EPM phone admin password. This issue is fixed in versions 16.0.96 and 17.0.10.
Neuron is a PHP framework for creating and orchestrating AI Agents. In versions 2.8.11 and below, the MySQLWriteTool executes arbitrary SQL provided by the caller using PDO::prepare() + execute() without semantic restrictions. This is consistent with the name (“write tool”), but in an LLM/agent context it becomes a high-risk capability: prompt injection or indirect prompt manipulation can cause execution of destructive queries such as DROP TABLE, TRUNCATE, DELETE, ALTER, or privilege-related statements (subject to DB permissions). Deployments that expose an agent with MySQLWriteTool enabled to untrusted input and/or run the tool with a DB user that has broad privileges are impacted. This issue is fixed in version 2.8.12.
Neuron is a PHP framework for creating and orchestrating AI Agents. Versions 2.8.11 and below use MySQLSelectTool, which is vulnerable to Read-Only Bypass. MySQLSelectTool is intended to be a read-only SQL tool (e.g., for LLM agent querying, however, validation based on the first keyword (e.g., SELECT) and a forbidden-keyword list does not block file-writing constructs such as INTO OUTFILE / INTO DUMPFILE. As a result, an attacker who can influence the tool input (e.g., via prompt injection through a public agent endpoint) may write arbitrary files to the DB server if the MySQL/MariaDB account has the FILE privilege and server configuration permits writes to a useful location (e.g., a web-accessible directory). This issue is fixed in version 2.8.12.
Okta Java Management SDK facilitates interactions with the Okta management API. In versions 11.0.0 through 20.0.0, race conditions may arise from concurrent requests using the ApiClient class. This could cause a status code or response header from one request’s response to influence another request’s response. This issue is fixed in version 20.0.1.
The Auth0 Next.js SDK is a library for implementing user authentication in Next.js applications. When using versions 4.11.0 through 4.11.2 and 4.12.0, simultaneous requests on the same client may result in improper lookups in the TokenRequestCache for the request results. This issue is fixed in versions 4.11.2 and 4.12.1.

Get company history
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.